Trial of Malaria Seasonal IPTc Combined With Community Case Management
Launched by CHEIKH ANTA DIOP UNIVERSITY, SENEGAL · Oct 6, 2011
Trial Information
Current as of June 17, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • age between 3 to 120 months
- • consent participation given by parents or guardians
- • willing to remain in the study area in the next 6 months
- Exclusion Criteria:
- • Known allergy to the study investigational drug
- • Any underlying chronic or severe condition.
- • Participant under Treatment with sulfamides
About Cheikh Anta Diop University, Senegal
Cheikh Anta Diop University, located in Dakar, Senegal, is a premier academic institution renowned for its commitment to research and innovation in various fields, including health sciences. As a clinical trial sponsor, the university leverages its extensive resources and expertise to advance medical knowledge and improve public health outcomes. With a focus on ethical research practices and collaboration with local and international partners, Cheikh Anta Diop University aims to address pressing health challenges in Senegal and beyond, fostering a culture of scientific inquiry and community engagement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Dakar, , Senegal
Patients applied
Trial Officials
Oumar Gaye, PhD
Study Director
Cheikh Anta Diop University, Senegal
Paul Milligan, PhD
Study Chair
London School of Hygiene and Tropical Medicine
Badara Cisse, PhD
Study Chair
Cheikh Anta Diop University, Senegal
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials